Recently stock market analysts have updated their consensus ratings on shares of Boston Scientific Corporation (NYSE:BSX). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/28/2016 – Boston Scientific Corporation had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 25 price target on the stock.

04/28/2016 – Boston Scientific Corporation had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 23 price target on the stock.

04/28/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 25 price target on the stock.

04/28/2016 – Boston Scientific Corporation had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 25 price target on the stock.

04/27/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Benchmark. They now have a USD 22 price target on the stock.

04/27/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 26 price target on the stock.

04/27/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 23.5 price target on the stock.

03/24/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Bank of America Merrill Lynch. They now have a USD 23 price target on the stock.

03/17/2016 – Nomura began new coverage on Boston Scientific Corporation giving the company a “buy” rating. They now have a USD 22 price target on the stock.

02/25/2016 – SunTrust began new coverage on Boston Scientific Corporation giving the company a “buy” rating. They now have a USD 21 price target on the stock.

01/04/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Sterne Agee. They now have a USD 22.5 price target on the stock.

11/12/2015 – Citigroup began new coverage on Boston Scientific Corporation giving the company a “buy” rating. They now have a USD 23 price target on the stock.

11/12/2015 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at BTIG Research. They now have a USD 20 price target on the stock.

11/11/2015 – Boston Scientific Corporation had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 21 price target on the stock.

11/11/2015 – Boston Scientific Corporation had its “hold” rating reiterated by analysts at Deutsche Bank. They now have a USD 19 price target on the stock.

Boston Scientific Corporation has a 50 day moving average of 19.72 and a 200 day moving average of 18.29. The stock’s market capitalization is 29.70B, it has a 52-week low of 14.18 and a 52-week high of 22.42.

The share price of the company (NYSE:BSX) was up +1.06% during the last trading session, with a high of 22.08 and the volume of Boston Scientific Corporation shares traded was 9715380.

View other investors thoughts on Boston Scientific Corporation on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.